Cargando…

Regulation of E-cadherin localization by microtubule targeting agents: rapid promotion of cortical E-cadherin through p130Cas/Src inhibition by eribulin

Microtubule targeting agents (MTAs) are some of the most effective anticancer drugs used to treat a wide variety of adult and pediatric cancers. Building evidence suggests that these drugs inhibit interphase signaling events and that this contributes to their anticancer actions. The effects of diver...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dybdal-Hargreaves, Nicholas F., Risinger, April L., Mooberry, Susan L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Priority Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5814157/ https://www.ncbi.nlm.nih.gov/pubmed/29464017 http://dx.doi.org/10.18632/oncotarget.23798

Ejemplares similares

Correction: Regulation of E-cadherin localization by microtubule targeting agents: rapid promotion of cortical E-cadherin through p130CAS/Src inhibition by eribulin
por: Dybdal-Hargreaves, Nicholas F., et al.
Publicado: (2019)

The Microtubule Destabilizer Eribulin Synergizes with STING Agonists to Promote Antitumor Efficacy in Triple-Negative Breast Cancer Models
por: Takahashi-Ruiz, Leila, et al.
Publicado: (2022)

Eribulin rapidly inhibits TGF-β-induced Snail expression and can induce Slug expression in a Smad4-dependent manner
por: Kaul, Roma, et al.
Publicado: (2019)

Correction: Eribulin rapidly inhibits TGF-β-induced Snail expression and can induce Slug expression in a Smad4-dependent manner
por: Kaul, Roma, et al.
Publicado: (2020)

Eribulin Activates the cGAS-STING Pathway via the Cytoplasmic Accumulation of Mitochondrial DNA
por: Fermaintt, Charles S., et al.
Publicado: (2021)

DDR1 promotes E-cadherin stability via inhibition of integrin-β1-Src activation-mediated E-cadherin endocytosis
por: Chen, Hong-Ru, et al.
Publicado: (2016)

Janus Compounds, 5-Chloro-N(4)-methyl-N(4)-aryl-9H-pyrimido[4,5-b]indole-2,4-diamines, Cause Both Microtubule Depolymerizing and Stabilizing Effects
por: Rohena, Cristina C., et al.
Publicado: (2016)

Desmoglein 3, via an Interaction with E-cadherin, Is Associated with Activation of Src
por: Tsang, Siu Man, et al.
Publicado: (2010)

429 Eribulin Synergizes with STING Agonists by Enhancing Type 1 Interferon Expression and Improves Antitumor Efficacy as Combination Treatment
por: Takahashi-Ruiz, Leila, et al.
Publicado: (2023)

Recycling of E-Cadherin: A Potential Mechanism for Regulating Cadherin Dynamics
por: Le, Tam Luan, et al.
Publicado: (1999)

Heparanase Loosens E-Cadherin-Mediated Cell-Cell Contact via Activation of Src
por: Cohen-Kaplan, Victoria, et al.
Publicado: (2020)

Prognostic significance of E-cadherin and N-cadherin expression in Gliomas
por: Noh, Myung-Giun, et al.
Publicado: (2017)

Synthetic Reactions with Rare Taccalonolides Reveal the Value of C-22,23 Epoxidation for Microtubule Stabilizing Potency
por: Peng, Jiangnan, et al.
Publicado: (2014)

Autoregulation of E-cadherin expression by cadherin–cadherin interactions: the roles of β-catenin signaling, Slug, and MAPK
por: Conacci-Sorrell, Maralice, et al.
Publicado: (2003)

E-cadherin evades endocytosis
por: LeBrasseur, Nicole
Publicado: (2004)

Distinct roles of cadherin-6 and E-cadherin in tubulogenesis and lumen formation
por: Jia, Liwei, et al.
Publicado: (2011)

E-cadherin to P-cadherin switching in lobular breast cancer with tubular elements
por: Christgen, Matthias, et al.
Publicado: (2020)

Src- and confinement-dependent FAK activation causes E-cadherin relaxation and β-catenin activity
por: Gayrard, Charlène, et al.
Publicado: (2018)

Src kinase inhibition restores E-cadherin expression in dasatinib-sensitive pancreatic cancer cells
por: Dosch, Austin R., et al.
Publicado: (2019)

Dynamic microtubules produce an asymmetric E-cadherin–Bazooka complex to maintain segment boundaries
por: Bulgakova, Natalia A., et al.
Publicado: (2013)

Alternate RASSF1 Transcripts Control SRC Activity, E-Cadherin Contacts, and YAP-Mediated Invasion
por: Vlahov, Nikola, et al.
Publicado: (2015)

E-Cadherin in a stabilizing relationship
por: LeBrasseur, Nicole
Publicado: (2002)

Expression of E-cadherin in pig kidney
por: Lee, Su-Youn, et al.
Publicado: (2013)

E-cadherin in Contact Inhibition and Cancer
por: Mendonsa, Alisha, et al.
Publicado: (2018)

E‐cadherin deregulation in breast cancer
por: Corso, Giovanni, et al.
Publicado: (2020)

Slug and E-Cadherin: Stealth Accomplices?
por: Sterneck, Esta, et al.
Publicado: (2020)

E-Cadherin: An Enigma in Pancreatic Diseases
por: Garrido, Vanessa T., et al.
Publicado: (2019)

NEDD9 and BCAR1 Negatively Regulate E-Cadherin Membrane Localization, and Promote E-Cadherin Degradation
por: Tikhmyanova, Nadezhda, et al.
Publicado: (2011)

E-Cadherin Can Replace N-Cadherin during Secretory-Stage Enamel Development
por: Guan, Xiaomu, et al.
Publicado: (2014)

Immunolocalization of β-catenin, E-cadherin and N-cadherin in neonate and adult rat kidney
por: TERADA, Naomi, et al.
Publicado: (2017)

eNOS-induced vascular barrier disruption in retinopathy by c-Src activation and tyrosine phosphorylation of VE-cadherin
por: Ninchoji, Takeshi, et al.
Publicado: (2021)

The Scribble Polarity Protein Stabilizes E-Cadherin/p120-Catenin Binding and Blocks Retrieval of E-Cadherin to the Golgi
por: Lohia, Madhura, et al.
Publicado: (2012)

The taccalonolides and paclitaxel cause distinct effects on microtubule dynamics and aster formation
por: Risinger, April L, et al.
Publicado: (2014)

N-Cadherin Promotes Motility in Human Breast Cancer Cells Regardless of Their E-Cadherin Expression
por: Nieman, Marvin T., et al.
Publicado: (1999)

Replacement of E-cadherin by N-cadherin in the mammary gland leads to fibrocystic changes and tumor formation
por: Kotb, Ahmed M, et al.
Publicado: (2011)

Distinct Mesenchymal Alterations in N-Cadherin and E-Cadherin Positive Primary Renal Epithelial Cells
por: Keller, Christof, et al.
Publicado: (2012)

Progression of Oral Squamous Cell Carcinoma Accompanied with Reduced E-Cadherin Expression but Not Cadherin Switch
por: Hashimoto, Takashi, et al.
Publicado: (2012)

Characteristics of bladder transitional cell carcinoma with E-cadherin and N-cadherin double-negative expression
por: LUO, YANG, et al.
Publicado: (2016)

The E-Cadherin and N-Cadherin Switch in Epithelial-to-Mesenchymal Transition: Signaling, Therapeutic Implications, and Challenges
por: Loh, Chin-Yap, et al.
Publicado: (2019)

Expression Patterns of E-Cadherin and N-Cadherin Proteins in the Periodontal Pocket Epithelium of Chronic Periodontitis
por: Kadeh, Hamideh, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ie85aref114uciv57t0bmiml4r